Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Tokai Pharma Cmn (TKAI)

N/A 0 (+0.00%)

N/A  N/A

Open:

N/A

Pre. Close:

N/A

High:

N/A

Low:

N/A

Volume:

0

Market Cap:

N/A

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.84 - 5.9

5.9 - 5.99

Low:

5.14 - 5.21

5.21 - 5.31

Close:

5.31 - 5.43

5.43 - 5.64

Technical analysis  (as of: 2017-05-25 4:51:12 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 6.69     One year: 7.45

Support:

Support1: 4.68    Support2: 3.89

Resistance:

Resistance1: 5.73    Resistance2: 6.38

Pivot:

5.57

Moving Averages:

MA(5): 5.68     MA(20): 5.57

MA(100): 7.42     MA(250): 16.94

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.22

%K %D:

%K(14,3): 52.35     %D(3): 59.67

RSI:

RSI(14): 42.96

52-Week:

High: 7.65  Low: 0.52  Change(%): -91.6

Average Vol(K):

3-Month: 17  10-Days 18

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TKAI has closed above bottom band by 42.2%. Bollinger Bands are 8.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 20 May 2017 21:56:15 GMT
Analysts Set Novus Therapeutics Inc (NVUS) PT at $1.15

Wed, 10 May 2017 07:30:00 GMT
Otic Pharma Completes Merger with Tokai Pharmaceuticals

Fri, 12 May 2017 11:37:30 GMT
Insider Trading Activity Novus Therapeutics Inc (NASDAQ:NVUS) – CEO Bought ...

Mon, 22 May 2017 17:48:45 GMT
13D Filing: Orbimed Israel Biofund GP Limited Partnership and Novus ...

Tue, 16 May 2017 02:48:45 GMT
Novus Therapeutics Inc (NVUS) Insider Catherine C. Turkel Acquires 11111 Shares

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

Shares Float (M)

% Held by Insiders

83.83

% Held by Institutions

29.00

Shares Short (K)

1110

Shares Short Prior Month (K)

1220

Stock Financials

EPS

-1.340

EPS Est. Current Year

-1.110

EPS Est. Next Year

-0.390

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-47.1

Return on Equity (ttm)

-85.7

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.620

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.52

Levered Free Cash Flow (M)

-22.15

FoxReading.com

Valuation

P/E

-4.07

P/E Growth Ratio

-0.02

P/BV

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.